Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects

NCT00000740 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

NIH

Sponsor class

Conditions

Pneumonia, Pneumocystis Carinii
HIV Infections

Interventions

DRUG: Sitamaquine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)